- Home
- ACIU vs REKR Comparison
ACIU vs REKR Comparison
Compare ACIU & REKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- REKR
- Stock Information
- Founded
- ACIU 2003
- REKR 2017
- Country
- ACIU Switzerland
- REKR United States
- Employees
- ACIU N/A
- REKR N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- REKR Telecommunications Equipment
- Sector
- ACIU Health Care
- REKR Telecommunications
- Exchange
- ACIU Nasdaq
- REKR Nasdaq
- Market Cap
- ACIU 168.7M
- REKR 153.5M
- IPO Year
- ACIU 2016
- REKR N/A
- Fundamental
- Price
- ACIU $2.07
- REKR $1.20
- Analyst Decision
- ACIU Strong Buy
- REKR
- Analyst Count
- ACIU 1
- REKR 0
- Target Price
- ACIU $12.00
- REKR N/A
- AVG Volume (30 Days)
- ACIU 119.1K
- REKR 6.5M
- Earning Date
- ACIU 08-05-2025
- REKR 08-13-2025
- Dividend Yield
- ACIU N/A
- REKR N/A
- EPS Growth
- ACIU N/A
- REKR N/A
- EPS
- ACIU N/A
- REKR N/A
- Revenue
- ACIU $32,014,254.00
- REKR $45,448,000.00
- Revenue This Year
- ACIU N/A
- REKR $8.68
- Revenue Next Year
- ACIU $533.21
- REKR $21.45
- P/E Ratio
- ACIU N/A
- REKR N/A
- Revenue Growth
- ACIU 91.20
- REKR 17.97
- 52 Week Low
- ACIU $1.43
- REKR $0.62
- 52 Week High
- ACIU $4.37
- REKR $2.67
- Technical
- Relative Strength Index (RSI)
- ACIU 59.88
- REKR 49.61
- Support Level
- ACIU $1.79
- REKR $1.08
- Resistance Level
- ACIU $2.10
- REKR $1.50
- Average True Range (ATR)
- ACIU 0.17
- REKR 0.12
- MACD
- ACIU 0.00
- REKR -0.03
- Stochastic Oscillator
- ACIU 71.93
- REKR 21.43
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which a majority of its revenue comes from the United States.